Bionano Genomics/$BNGO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bionano Genomics
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
Ticker
$BNGO
Sector
Primary listing
Employees
99
Headquarters
Website
Bionano Genomics Metrics
BasicAdvanced
$19M
-
-$32.25
2.06
-
Price and volume
Market cap
$19M
Beta
2.06
52-week high
$6.32
52-week low
$2.68
Average daily volume
122K
Financial strength
Current ratio
1.764
Quick ratio
0.824
Long term debt to equity
13.697
Total debt to equity
43.15
Interest coverage (TTM)
-91.34%
Profitability
EBITDA (TTM)
-37.855
Gross margin (TTM)
5.06%
Net profit margin (TTM)
-271.02%
Operating margin (TTM)
-184.85%
Effective tax rate (TTM)
-0.06%
Revenue per employee (TTM)
$280,000
Management effectiveness
Return on assets (TTM)
-30.86%
Return on equity (TTM)
-118.25%
Valuation
Price to revenue (TTM)
0.347
Price to book
0.36
Price to tangible book (TTM)
0.42
Price to free cash flow (TTM)
-0.365
Free cash flow yield (TTM)
-273.85%
Free cash flow per share (TTM)
-11.31
Growth
Revenue change (TTM)
-25.02%
Earnings per share change (TTM)
-87.15%
3-year revenue growth (CAGR)
5.55%
3-year earnings per share growth (CAGR)
-47.58%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Bionano Genomics stock?
Bionano Genomics (BNGO) has a market cap of $19M as of August 23, 2025.
What is the P/E ratio for Bionano Genomics stock?
The price to earnings (P/E) ratio for Bionano Genomics (BNGO) stock is 0 as of August 23, 2025.
Does Bionano Genomics stock pay dividends?
No, Bionano Genomics (BNGO) stock does not pay dividends to its shareholders as of August 23, 2025.
When is the next Bionano Genomics dividend payment date?
Bionano Genomics (BNGO) stock does not pay dividends to its shareholders.
What is the beta indicator for Bionano Genomics?
Bionano Genomics (BNGO) has a beta rating of 2.06. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.